Booke mark this website!
home my account view cart otc Welcome! - Login Register
Toll Free Tel: 1-877-270-3784
Toll Free Fax: 1-877-777-9144 . 1-877-703-3005
Drug Search
McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams Privacy Policy by TRUSTe

Click to Call

Download
Order Forms

Get Adobe Acrobat


Buy Abilify Buy Advair
Buy Cialis Buy Flovent
Buy Geodon Buy Januvia
Buy Levaquin Buy Lipitor
Buy Lovenox Buy Nasonex
Buy Nexium Buy Plavix
Buy Singulair Buy Seroquel
Buy Viagra Buy Vytorin
Buy Zetia 

4 Tips to Keep Your Heart Healthy

How to Minimize Risk of Heart Disease

Healthy Winter Diet for Strong Immune System

Does Caffeine Benefit or Worsen Depression?

Choosing an Online Canadian Pharmacy

Canadian Online Pharmacies

How To Find A Canadian Internet Pharmacy

Cheap Canadian Drugs

Top 10 Most Popular
Over the Counter meds


Canada drugs



Share/Bookmark

Canadian Company Launches Drug in US



A Canadian drug company has received approval from the US Food and Drug Administration (FDA) to launch its new drug in the States. Theratechnologies Inc, a Canadian drug company based in Montreal, has been given the go-ahead for the launch of its tesamorelin drug, to be marketed as Egrifta, in the country. The Canada drug company has spent more than fifteen years and two hundred million dollars developing the drug, which according to the FDA is “the first and only treatment indicated to reduce excess abdominal fat in HIV infected patients with lipodystrophy”.

The Canada drug will go on sale in the United States within weeks now that the approval has been given, according to Theratechnologies Inc CEO Yves Rosconi.

“There are two hundred and thirty thousand patients waiting out there for this treatment in the US alone,” Rosconi claims. “We’re actively seeking partners to help file for regulatory approval in Canada, Europe and Latin America, where the drug is also needed.”

Patients can inject the drug themselves using a very thin needle, although the FDA will still require more investigation into the safety of the drug - despite it already being approved - including checks on long term use and its impact on diabetic HIV patients. “We’re one of the very few Canadian biotech firms to have successfully discovered, developed and brought a drug to market on its own and FDA approval is a real achievement for patients and for our shareholders,” Rosconi stated proudly. “This drug is destined to make a difference.”
Canada Drug Center | How To Order | Customer Care | About Pharmacy | Contact Pharmacy
Policies | Sitemap | Over The Counter Meds | Blog

CanadaDrugCenter Pharmacy Accreditation


Copyright © 2007-2017 by CanadaDrugCenter.com - All rights reserved.